7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Yumanity Therapeutics Inc
(NASDAQ:YMTX) 

YMTX stock logo

Yumanity Therapeutics Inc., a clinical-stage biopharmaceutical company, is dedicated to the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company is headquartered in Boston, Massachusetts.

Founded: 2014
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS

Share this website to your friends
Yumanity Therapeutics Op Cashflow Per Share ttm
202206 202207 202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 -16.47-14.11-11.76-9.41-7.06-4.7-2.350
Yumanity Therapeutics Free Cashflow Per Share ttm
202206 202207 202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 -16.55-14.19-11.82-9.46-7.09-4.73-2.360
Yumanity Therapeutics Cash Per Share ttm
202206 202207 202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 01.212.433.644.866.077.298.5
Yumanity Therapeutics P/S ratio ttm
202206 202207 202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 01.853.715.567.429.2711.1312.98
Yumanity Therapeutics (GAAP) P/E ratio ttm
202206 202207 202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 -0.58-0.5-0.42-0.33-0.25-0.17-0.080
Yumanity Therapeutics P/B ratio ttm
202206 202207 202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 -91.34-77.81-64.27-50.73-37.2-23.66-10.133.41
No extra charts and metrics for this ticker.